101. Epidemiology and clinical features of childhood-onset anti-neutrophil cytoplasmic antibody-associated vasculitis: a clinicopathological analysis
- Author
-
Hirano, Daishi, Ishikawa, Tomoaki, Inaba, Aya, Sato, Mai, Shinozaki, Tomohiro, Iijima, Kazumoto, and Ito, Shuichi
- Subjects
Children -- Diseases ,Vasculitis -- Diagnosis -- Demographic aspects -- Patient outcomes ,Chronic kidney failure -- Demographic aspects -- Development and progression -- Causes of ,Health - Abstract
Background This study was performed to determine the clinical features and outcomes of childhood-onset anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV), particularly microscopic polyangiitis (MPA). Methods A retrospective Japanese multicenter study was performed in patients diagnosed with AAV before 16 years of age. Results Of 49 patients with AAV, 36 were female. The diagnoses were as follows: MPA (n = 38, 78%), granulomatosis with polyangiitis (GPA; n = 9, 18%), eosinophilic granulomatosis with polyangiitis (EGPA; n = 1, 2%), and other (n = 1, 2%). The median age at onset was 10.7 years, and median time to diagnosis was 2.0 months. Twenty-seven (55%) patients were identified through a school urinary screening program. Initial symptoms included fever and fatigue (45%), and renal (71%), pulmonary (29%), ocular (20%), and mucocutaneous involvement (22%). Although 27 (55%) patients achieved remission and none had died at the last follow-up, at least one recurrence occurred in 13 (48%) patients after a median of 48 months and was more common in patients with GPA (P < 0.01). After a median follow-up of 43 months, seven (14%) patients (all with MPA) progressed to end-stage renal disease (ESRD). Conclusions Childhood-onset AAV has an estimated prevalence of 3.41-4.28 per million children and is characterized by female predominance and high frequency of detection in school urinary screening programs. More than 10% of patients with childhood-onset AAV still progress to ESRD without achieving remission. Histological chronicity is a factor associated with ESRD., Author(s): Daishi Hirano [sup.1] , Tomoaki Ishikawa [sup.2] , Aya Inaba [sup.3] , Mai Sato [sup.4] , Tomohiro Shinozaki [sup.5] , Kazumoto Iijima [sup.6] , Shuichi Ito [sup.7] Author Affiliations: [...]
- Published
- 2019
- Full Text
- View/download PDF